Benchmark Holdings, the global aquaculture genetics, health and specialist nutrition firm, raised £20.7 million (€24.5 million/$27.6 million) by way of a share issue as it eyes a potential listing on the Oslo Stock Exchange.

Following a substantial reorganization completed in 2020, Benchmark said it has delivered a good financial performance in 2021, including in the fourth quarter, demonstrating the success of its renewed commercial focus and financial discipline.

The net proceeds of the share issue will provide the company with additional headroom to maintain this momentum and continue to fund its ongoing growth initiatives, which may include additional CleanTreat systems to support the rollout of Ectosan Vet and CleanTreat if demand requires.